• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Infect Control . Retrospective evaluation of the symptom-based work restriction strategy of healthcare providers in the first epidemic of COVI

tetano

Editor, Senior Moderator
Am J Infect Control


. 2021 Dec 8;S0196-6553(21)00797-5.
doi: 10.1016/j.ajic.2021.11.029. Online ahead of print.
Retrospective evaluation of the symptom-based work restriction strategy of healthcare providers in the first epidemic of COVID-19 at a tertiary care hospital in Tokyo, Japan


Hiroki Shikano[SUP] 1 [/SUP], Yuki Uehara[SUP] 2 [/SUP], Rino Kuboki[SUP] 1 [/SUP], Erika Tashino[SUP] 1 [/SUP], Fumiko Nakahara[SUP] 1 [/SUP], Yumi Matsumoto[SUP] 1 [/SUP], Satomi Kusakabe[SUP] 1 [/SUP], Chizumi Fukazawa[SUP] 1 [/SUP], Takahiro Matsuo[SUP] 3 [/SUP], Nobuyoshi Mori[SUP] 3 [/SUP], Akiko Ayabe[SUP] 4 [/SUP], Torahiko Jinta[SUP] 5 [/SUP], Fumika Taki[SUP] 6 [/SUP], Fumie Sakamoto[SUP] 7 [/SUP], Osamu Takahashi[SUP] 8 [/SUP], Tsuguya Fukui[SUP] 8 [/SUP]



Affiliations

Abstract

Background: Effectiveness of restricting healthcare providers (HCPs) from working based on the coronavirus disease 2019 (COVID-19)-like symptoms should be evaluated.
Methods: A total of 495 HCPs in a tertiary care hospital in Tokyo, Japan, participated in this study between June and July in 2020. Analysis of serum anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody to identify infected HCPs, questionnaire surveys, and medical record reviews were conducted to evaluate the appropriateness of symptom-based work restriction for 10 days.
Results: Five participants (1.0%) were identified as infected. Forty-six participants (9.3%) experienced work restriction and all five infected participants (10.8%) restricted working, even though the real-time reverse transcription-polymerase chain reaction was positive only in four participants (80.0%). There were no unexpectedly infected participants among those who did not experience work restriction. However, only 46 of 110 HCPs with COVID-19-like symptoms (41.8%) restricted themselves from working.
Discussion: Symptom-based work restriction strategy successfully prevented infected HCPs to work, but showed low specificity to identify truly infected HCPs, and their low adherence to the strategy was revealed.
Conclusions: HCPs with COVID-19-like symptoms should restrict working as the first step of infection prevention, but the strategy to identify truly infected HCPs is necessary.

Keywords: acute respiratory syndrome coronavirus 2; allergic rhinitis; coronavirus disease 2019; healthcare providers; symptom-based work restriction.
 
Back
Top Bottom